US Edition
HHS chief RFK Jr. says he’s ordered a ‘complete review’ of chemical abortion pill
- On May 2025, U.S. Health Secretary Robert F. Kennedy Jr. Ordered a comprehensive review of mifepristone, the abortion pill approved 25 years ago and widely used nationwide.
- The review comes in response to a disputed report from a conservative think tank that alleges over 10% of users experienced serious adverse effects, although the report has not undergone peer review or been published in a medical journal.
- Kennedy testified before the Senate, emphasizing safety concerns and instructing FDA director Marty Makary to lead the review despite FDA officials maintaining no current plans to change pill approval.
- The report analyzed 865,727 chemical abortions from 2017 to 2023 and found adverse event rates 22 times higher than prior clinical trials, including ER visits, hemorrhages, and infections.
- This review could signal a shift in federal reproductive health policy, eliciting criticism from reproductive rights groups who warn that restricting access may endanger patients and undermine established drug safety records.
49 Articles
49 Articles
MedPage Today
Anti-Aging, Acupuncture and Health NewsWaiting Period Extends Abortion Wait Beyond Mandatory 24 Hours
(MedPage Today) -- MINNEAPOLIS -- Mandatory 24-hour waiting periods between consent and abortion visits often resulted in much longer waits than required, a prospective survey study found. The median interval between the two visits was 3 days...
Abortion providers challenge FDA’s remaining mifepristone restrictions in federal court • South Dakota Searchlight
“We just want to ensure that the most popular method for abortion in Virginia and beyond is protected no matter who sits at the White House and who sits in the FDA,” said Whole Woman’s Health founder and president Amy Hagstrom Miller outside of the U.S. District Court of the Western District of Virginia in Charlottesville, Virginia, on May 19, 2025. (Photo by Charlotte Rene Woods/Virginia Mercury)CHARLOTTESVILLE, Va. — Abortion pills — and quest…
InsideNoVA.com
Abortion providers challenge FDA’s remaining mifepristone restrictions in federal court
CHARLOTTESVILLE, Va. — Abortion pills — and questions over their inherent safety — were back in federal court Monday. Unlike a lawsuit rejected by the U.S. Supreme Court last year, plaintiffs this time are not anti-abortion activists arguing medication abortion…
HHS Secretary Asked to Make Good on Promise to Review Abortion Pill
A conservative think tank is seeking to hold Secretary of Health and Human Services Robert F. Kennedy Jr. to his commitment to review the safety and efficacy of the abortion pill. “I’ve asked Marty Makary, who’s the director of [the Food and Drug Administration], to do a complete review, and to report back,” Kennedy said at a May 14 Senate committee hearing. Advancing American Freedom, a conservative think tank founded by former Vice President M…
Coverage Details
Bias Distribution
- 63% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
